Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Ford
F
$57.5B
| $2.87M | 0.05% |
235,591
-97,824
| -29% | -$1.09M |
|
477
Zoom
ZM
$31.5B
| $2.86M | 0.05% |
39,821
-7,633
| -16% | -$505K |
|
478
Zimmer Biomet
ZBH
$19.3B
| $2.86M | 0.05% |
23,506
-20,599
| -47% | -$2.3M |
|
479
TransUnion
TRU
$16.2B
| $2.86M | 0.05% |
41,633
-9,238
| -18% | -$563K |
|
480
Littelfuse
LFUS
$10.5B
| $2.83M | 0.05% |
10,588
+3,640
| +52% | +$872K |
|
481
Lantheus
LNTH
$6.53B
| $2.82M | 0.05% |
45,447
-25,978
| -36% | -$1.76M |
|
482
Primerica
PRI
$9.1B
| $2.79M | 0.05% |
13,553
+1,484
| +12% | +$303K |
|
483
California Resources
CRC
$4.73B
| $2.78M | 0.05% |
50,790
+17,889
| +54% | +$941K |
|
484
Regeneron Pharmaceuticals
REGN
$85.9B
| $2.77M | 0.05% |
3,149
-98
| -3% | -$80.7K |
|
485
Abercrombie & Fitch
ANF
$4.84B
| $2.75M | 0.05% |
31,195
-5,446
| -15% | -$388K |
|
486
Align Technology
ALGN
$11.5B
| $2.75M | 0.05% |
10,030
-11,156
| -53% | -$2.64M |
|
487
Insight Enterprises
NSIT
$4.33B
| $2.74M | 0.05% |
15,486
-7,373
| -32% | -$1.15M |
|
488
MKS Inc
MKSI
$18.9B
| $2.74M | 0.05% |
26,658
-3,503
| -12% | -$285K |
|
489
ScottsMiracle-Gro
SMG
$3.55B
| $2.73M | 0.05% |
42,899
-367
| -0.8% | -$19.8K |
|
490
Paychex
PAYX
$44.3B
| $2.73M | 0.05% |
22,901
-39,837
| -63% | -$4.72M |
|
491
Charter Communications
CHTR
$17.9B
| $2.72M | 0.05% |
7,006
-853
| -11% | -$348K |
|
492
Performance Food Group
PFGC
$16.5B
| $2.72M | 0.05% |
39,369
-7,191
| -15% | -$442K |
|
493
JPMorgan Core Plus Bond ETF
JCPB
$14.3B
| $2.72M | 0.05% |
+57,790
| New | +$2.61M |
|
494
Murphy Oil
MUR
$5.36B
| $2.72M | 0.05% |
63,720
+32,696
| +105% | +$1.43M |
|
495
Columbia Sportswear
COLM
$3.09B
| $2.7M | 0.05% |
33,986
-23,710
| -41% | -$1.81M |
|
496
Interactive Brokers
IBKR
$42.5B
| $2.7M | 0.05% |
130,284
-14,368
| -10% | -$294K |
|
497
Quaker Houghton
KWR
$2.81B
| $2.7M | 0.05% |
12,632
+1,464
| +13% | +$252K |
|
498
Norwegian Cruise Line
NCLH
$7.92B
| $2.69M | 0.05% |
134,460
-39,529
| -23% | -$634K |
|
499
Cincinnati Financial
CINF
$25.8B
| $2.69M | 0.05% |
25,953
-25,879
| -50% | -$2.63M |
|
500
West Pharmaceutical
WST
$24.8B
| $2.68M | 0.05% |
7,624
-3,594
| -32% | -$1.27M |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.